NO and the Vasculature: Where Does It Come from and What Does It Do?

[1]  M. Kirsch,et al.  Formation of Peroxynitrite from Reaction of Nitroxyl Anion with Molecular Oxygen* , 2002, Journal of Biological Chemistry.

[2]  S. Fujii,et al.  In vivo nitric oxide transfer of a physiological NO carrier, dinitrosyl dithiolato iron complex, to target complex. , 2002, Biochemical pharmacology.

[3]  C. Triggle,et al.  Vascular smooth muscle relaxation mediated by nitric oxide donors: a comparison with acetylcholine, nitric oxide andnitroxyl ion , 2001, British journal of pharmacology.

[4]  F. Faraci,et al.  Superoxide levels and function of cerebral blood vessels after inhibition of CuZn-SOD. , 2001, American journal of physiology. Heart and circulatory physiology.

[5]  D. Gozal,et al.  S-Nitrosothiols signal the ventilatory response to hypoxia , 2001, Nature.

[6]  Z. Katusic.  Vascular endothelial dysfunction: does tetrahydrobiopterin play a role? , 2001, American journal of physiology. Heart and circulatory physiology.

[7]  K. Moore,et al.  Formation of nanomolar concentrations of S-nitroso-albumin in human plasma by nitric oxide. , 2001, Free radical biology & medicine.

[8]  B. Mutus,et al.  Mechanism of transfer of NO from extracellular S-nitrosothiols into the cytosol by cell-surface protein disulfide isomerase , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[9]  C. Triggle,et al.  State-dependent block of rabbit vascular smooth muscle delayed rectifier and Kv1.5 channels by inhibitors of cytochrome P450-dependent enzymes. , 2001, The Journal of pharmacology and experimental therapeutics.

[10]  C. Triggle,et al.  Endothelium-derived relaxing factors: a focus on endothelium-derived hyperpolarizing factor(s). , 2001, Canadian journal of physiology and pharmacology.

[11]  C. Wilcox,et al.  The SOD mimetic tempol restores vasodilation in afferent arterioles of experimental diabetes. , 2001, Kidney international.

[12]  P. Riederer,et al.  Nitroxyl oxidizes NADPH in a superoxide dismutase inhibitable manner. , 2001, Free radical biology & medicine.

[13]  E. Werner,et al.  Reactive Oxygen Species Mediate Endothelium-Dependent Relaxations in Tetrahydrobiopterin-Deficient Mice , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[14]  J. Y. Park,et al.  The effects of thiol compounds and ebselen on nitric oxide activity in rat aortic vascular responses. , 2001, Journal of autonomic pharmacology.

[15]  R. Busse,et al.  Endothelium-Derived Hyperpolarizing Factor Synthase (Cytochrome P450 2C9) Is a Functionally Significant Source of Reactive Oxygen Species in Coronary Arteries , 2001, Circulation research.

[16]  D. Wink,et al.  Unique Oxidative Mechanisms for the Reactive Nitrogen Oxide Species, Nitroxyl Anion* , 2001, The Journal of Biological Chemistry.

[17]  J. Huidobro-Toro,et al.  Nitric oxide synthase-independent release of nitric oxide induced by KCl in the perfused mesenteric bed of the rat. , 2000, European journal of pharmacology.

[18]  Qian Wang,et al.  Arginine Conversion to Nitroxide by Tetrahydrobiopterin-free Neuronal Nitric-oxide Synthase , 2000, The Journal of Biological Chemistry.

[19]  Y. Zhao,et al.  Inhibition of soluble guanylate cyclase by ODQ. , 2000, Biochemistry.

[20]  A. Danser,et al.  L‐NAME‐resistant bradykinin‐induced relaxation in porcine coronary arteries is NO‐dependent: effect of ACE inhibition , 2000, British journal of pharmacology.

[21]  F. W. Flitney,et al.  Selective modifiers of glutathione biosynthesis and ‘repriming’ of vascular smooth muscle photorelaxation , 2000, British journal of pharmacology.

[22]  M. Gladwin,et al.  Effect of nitric oxide and nitric oxide donors on red blood cell oxygen transport , 2000, British journal of haematology.

[23]  J. van de Voorde,et al.  Endothelial dysfunction in diabetes , 2000, British journal of pharmacology.

[24]  G. He,et al.  Endothelium-dependent hyperpolarization and relaxation resistance to N(G)-nitro-L-arginine and indomethacin in coronary circulation. , 2000, Cardiovascular research.

[25]  T. W. Secomb,et al.  The endothelial surface layer , 2000, Pflügers Archiv.

[26]  Ç. Karasu.  Time course of changes in endothelium-dependent and -independent relaxation of chronically diabetic aorta: role of reactive oxygen species. , 2000, European journal of pharmacology.

[27]  R. Cohen,et al.  Decreased aortic glutathione levels may contribute to impaired nitric oxide‐induced relaxation in hypercholesterolaemia , 2000, British journal of pharmacology.

[28]  G. Balogh,et al.  Cytochrome P450 Catalyzed Nitric Oxide Synthesis: A Theoretical Study , 2000, Journal of biomolecular structure & dynamics.

[29]  M. Rand,et al.  Differential actions of L‐cysteine on responses to nitric oxide, nitroxyl anions and EDRF in the rat aorta , 2000, British journal of pharmacology.

[30]  F. Gao,et al.  Opposite effects of nitric oxide and nitroxyl on postischemic myocardial injury. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[31]  B. Kalyanaraman,et al.  Mechanism of superoxide dismutase/H(2)O(2)-mediated nitric oxide release from S-nitrosoglutathione--role of glutamate. , 1999, Archives of biochemistry and biophysics.

[32]  A. Herman,et al.  Neocuproine potentiates the activity of the nitrergic neurotransmitter but inhibits that of S-nitrosothiols. , 1999, European journal of pharmacology.

[33]  S. Gupte,et al.  Inhibition of guanylate cyclase stimulation by NO and bovine arterial relaxation to peroxynitrite and H2O2. , 1999, The American journal of physiology.

[34]  M. Foster,et al.  Detection of nitrosyl-iron complexes by proton-electron-double-resonance imaging. , 1999, Free radical biology & medicine.

[35]  J. Stamler,et al.  The oxyhemoglobin reaction of nitric oxide. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[36]  H. Schmidt,et al.  The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation. , 1999, Molecular pharmacology.

[37]  K. Hansen,et al.  Methodologic aspects of acetylcholine-evoked relaxation of rabbit aorta. , 1999, Journal of pharmacological and toxicological methods.

[38]  W. Martin,et al.  Effects of superoxide dismutase mimetics on the activity of nitric oxide in rat aorta , 1999, British journal of pharmacology.

[39]  J. van de Voorde,et al.  Influence of some phospholipase A2 and cytochrome P450 inhibitors on rat arterial smooth muscle K+ currents. , 1999, Canadian journal of physiology and pharmacology.

[40]  M. Rand,et al.  Comparison of the redox forms of nitrogen monoxide with the nitrergic transmitter in the rat anococcygeus muscle , 1999, British journal of pharmacology.

[41]  G. Burnstock,et al.  Free radical involvement in endothelium-dependent responses of the rat thoracic aorta in moderate hypoxic conditions. , 1999, European journal of pharmacology.

[42]  M. N. Hughes,et al.  Relationships between nitric oxide, nitroxyl ion, nitrosonium cation and peroxynitrite. , 1999, Biochimica et biophysica acta.

[43]  H. Ohshima,et al.  Induction of DNA strand breakage and base oxidation by nitroxyl anion through hydroxyl radical production. , 1999, Free radical biology & medicine.

[44]  M. Mulvany,et al.  In vitro simultaneous measurements of relaxation and nitric oxide concentration in rat superior mesenteric artery , 1999, The Journal of physiology.

[45]  C. O. Wambi-Kiéssé,et al.  Inhibition of copper/zinc superoxide dismutase impairs NO.-mediated endothelium-dependent relaxations. , 1999, The American journal of physiology.

[46]  J. Loscalzo,et al.  Cell-surface protein disulfide isomerase catalyzes transnitrosation and regulates intracellular transfer of nitric oxide. , 1999, The Journal of clinical investigation.

[47]  R. Andriantsitohaina,et al.  Mechanism of endothelial nitric oxide-dependent vasorelaxation induced by wine polyphenols in rat thoracic aorta. , 1999, Journal of cardiovascular pharmacology.

[48]  G. Angelini,et al.  Investigation of the inhibitory effects of homocysteine and copper on nitric oxide‐mediated relaxation of rat isolated aorta , 1999, British journal of pharmacology.

[49]  P. Chowienczyk,et al.  Effects of vitamin C and of a cell permeable superoxide dismutase mimetic on acute lipoprotein induced endothelial dysfunction in rabbit aortic rings , 1999, British journal of pharmacology.

[50]  T. Griffith,et al.  Nitric oxide-independent relaxations to acetylcholine and A23187 involve different routes of heterocellular communication. Role of Gap junctions and phospholipase A2. , 1999, Circulation research.

[51]  D. Wink,et al.  Effect of Superoxide Dismutase on the Stability ofS-Nitrosothiols , 1999 .

[52]  R. Gillette,et al.  Non-enzymatic production of nitric oxide (NO) from NO synthase inhibitors. , 1998, Biochemical and biophysical research communications.

[53]  M. Akpaffiong,et al.  Antihypertensive and vasodilator actions of antioxidants in spontaneously hypertensive rats. , 1998, American journal of hypertension.

[54]  M. Marletta,et al.  Reactions catalyzed by tetrahydrobiopterin-free nitric oxide synthase. , 1998, Biochemistry.

[55]  J. Keaney,et al.  Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. , 1998, Circulation research.

[56]  B. Tołłoczko,et al.  Nitric oxide synthesis by tracheal smooth muscle cells by a nitric oxide synthase-independent pathway. , 1998, American journal of physiology. Lung cellular and molecular physiology.

[57]  J. Zweier,et al.  Superoxide Generation from Endothelial Nitric-oxide Synthase , 1998, The Journal of Biological Chemistry.

[58]  M. Dikshit,et al.  Role of endothelial-derived reactive oxygen species and nitric oxide in norepinephrine-induced rat aortic ring contractions. , 1998, Pharmacological research.

[59]  W. Martin,et al.  Recovery by ascorbate of impaired nitric oxide‐dependent relaxation resulting from oxidant stress in rat aorta , 1998, British journal of pharmacology.

[60]  Manjeet Singh,et al.  Possible mechanism of captopril induced endothelium-dependent relaxation in isolated rabbit aorta , 1998, Molecular and Cellular Biochemistry.

[61]  P. Chabrier,et al.  Comparison between endothelial and neuronal nitric oxide pathways in rat aorta and gastric fundus. , 1998, Nitric oxide : biology and chemistry.

[62]  W. Martin,et al.  Loss of endothelium‐derived nitric oxide in rabbit aorta by oxidant stress: restoration by superoxide dismutase mimetics , 1998, British journal of pharmacology.

[63]  C. Cooper,et al.  Reactions of nitric oxide with mitochondrial cytochrome c: a novel mechanism for the formation of nitroxyl anion and peroxynitrite. , 1998, The Biochemical journal.

[64]  C. Triggle,et al.  Involvement of nitrosothiols, nitric oxide and voltage-gated K+ channels in photorelaxation of vascular smooth muscle. , 1998, European journal of pharmacology.

[65]  D. Jensen,et al.  S-Nitrosoglutathione is a substrate for rat alcohol dehydrogenase class III isoenzyme. , 1998, The Biochemical journal.

[66]  H Ishii,et al.  Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[67]  B. Freeman,et al.  Xanthine Oxidase-mediated Decomposition ofS-Nitrosothiols* , 1998, The Journal of Biological Chemistry.

[68]  R. Cohen,et al.  Evidence that different mechanisms underlie smooth muscle relaxation to nitric oxide and nitric oxide donors in the rabbit isolated carotid artery , 1998, British journal of pharmacology.

[69]  H. Nagasawa,et al.  Reaction between S-nitrosothiols and thiols: generation of nitroxyl (HNO) and subsequent chemistry. , 1998, Biochemistry.

[70]  S. Aleryani,et al.  Superoxide-mediated Decomposition of BiologicalS-Nitrosothiols* , 1998, The Journal of Biological Chemistry.

[71]  Xiaoping Liu,et al.  Accelerated reaction of nitric oxide with O2 within the hydrophobic interior of biological membranes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[72]  James B. Mitchell,et al.  The cytotoxicity of nitroxyl: possible implications for the pathophysiological role of NO. , 1998, Archives of biochemistry and biophysics.

[73]  J. Hothersall,et al.  Cell-mediated biotransformation of S-nitrosoglutathione. , 1998, Biochemical pharmacology.

[74]  M. Nishio,et al.  Characterization of a streptococcal antitumor glycoprotein (SAGP). , 1998, Life Science.

[75]  J. Stamler,et al.  Reactions between nitric oxide and haemoglobin under physiological conditions , 1998, Nature.

[76]  H. Maeda,et al.  Effect of the NO scavenger carboxy-ptio on endothelium-dependent vasorelaxation of various blood vessels from rabbits. , 1997, Life sciences.

[77]  J. van de Voorde,et al.  Nitric oxide induced membrane hyperpolarization in the rat aorta is not mediated by glibenclamide-sensitive potassium channels. , 1997, Canadian journal of physiology and pharmacology.

[78]  A. Hobbs.  Soluble guanylate cyclase: the forgotten sibling. , 1997, Trends in pharmacological sciences.

[79]  G. Pieper,et al.  Use of a nitronyl nitroxide to discriminate the contribution of nitric oxide radical in endothelium-dependent relaxation of control and diabetic blood vessels. , 1997, The Journal of pharmacology and experimental therapeutics.

[80]  I. Quéré,et al.  Effects of homocysteine on acetylcholine‐ and adenosine‐induced vasodilatation of pancreatic vascular bed in rats , 1997, British journal of pharmacology.

[81]  S. Bisland,et al.  Neocuproine, a selective Cu(I) chelator, and the relaxation of rat vascular smooth muscle by S‐nitrosothiols , 1997, British journal of pharmacology.

[82]  A. Butler,et al.  Chemistry, analysis, and biological roles of S-nitrosothiols. , 1997, Analytical biochemistry.

[83]  G. Angelini,et al.  Effect of copper on nitric oxide synthase and guanylyl cyclase activity in the rat isolated aorta , 1997, British journal of pharmacology.

[84]  R. Cohen,et al.  Nitric oxide is the mediator of both endothelium-dependent relaxation and hyperpolarization of the rabbit carotid artery. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[85]  J. Joseph,et al.  S-Nitrosoglutathione as a substrate for γ-glutamyl transpeptidase , 1997 .

[86]  F. Bonner,et al.  The Chemistry of Nitric Oxide and Redox‐Related Species , 1997 .

[87]  B. Nilius,et al.  Calcium-activated potassium channels in cultured human endothelial cells are not directly modulated by nitric oxide. , 1997, Cell calcium.

[88]  C. Sobey,et al.  Effects of a novel inhibitor of guanylyl cyclase on dilator responses of mouse cerebral arterioles. , 1997, Stroke.

[89]  T. Cocks,et al.  Evidence that mechanisms dependent and independent of nitric oxide mediate endothelium‐dependent relaxation to bradykinin in human small resistance‐like coronary arteries , 1997, British journal of pharmacology.

[90]  J. Stamler,et al.  N-acetylcysteine does not influence the activity of endothelium-derived relaxing factor in vivo. , 1997, Hypertension.

[91]  J. R. Lancaster.  A tutorial on the diffusibility and reactivity of free nitric oxide. , 1997, Nitric oxide : biology and chemistry.

[92]  H. Schmidt,et al.  No .NO from NO synthase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[93]  B. Muller,et al.  Evidence for N‐acetylcysteine‐sensitive nitric oxide storage as dinitrosyl‐iron complexes in lipopolysaccharide‐treated rat aorta , 1996, British journal of pharmacology.

[94]  P. Zygmunt,et al.  Effects of cytochrome P450 inhibitors on potassium currents and mechanical activity in rat portal vein , 1996, British journal of pharmacology.

[95]  A. Holmgren,et al.  S-Nitrosoglutathione Is Cleaved by the Thioredoxin System with Liberation of Glutathione and Redox Regulating Nitric Oxide* , 1996, The Journal of Biological Chemistry.

[96]  J. Joseph,et al.  Mechanism of Nitric Oxide Release from S-Nitrosothiols* , 1996, The Journal of Biological Chemistry.

[97]  D. L. Williams,et al.  Generation of nitric oxide from S-nitrosothiols using protein-bound Cu2+ sources. , 1996, Chemistry & biology.

[98]  B. Mayer,et al.  Inhibition of nitric oxide synthesis by NG‐nitro‐L‐arginine methyl ester (L‐NAME): requirement for bioactivation to the free acid, NG‐nitro‐L‐arginine , 1996, British journal of pharmacology.

[99]  B. Mayer,et al.  Decomposition of S-nitrosoglutathione in the presence of copper ions and glutathione. , 1996, Archives of biochemistry and biophysics.

[100]  E. Manukhina,et al.  Physical properties of dinitrosyl iron complexes with thiol-containing ligands in relation with their vasodilator activity. , 1996, Biochimica et biophysica acta.

[101]  C. Triggle,et al.  Nitric oxide, a possible mediator of 1,4‐dihydropyridine‐induced photorelaxation of vascular smooth muscle , 1996, British journal of pharmacology.

[102]  B. Mayer,et al.  Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery. , 1996, The Journal of pharmacology and experimental therapeutics.

[103]  B. Kalyanaraman,et al.  The role of glutathione in the transport and catabolism of nitric oxide , 1996, FEBS letters.

[104]  M. La,et al.  Comparison of the effects of hydroxocobalamin and oxyhaemoglobin on responses to NO, EDRF and the nitrergic transmitter , 1996, British journal of pharmacology.

[105]  R. Zamora,et al.  Oxidative release of nitric oxide accounts for guanylyl cyclase stimulating, vasodilator and anti-platelet activity of Piloty's acid: a comparison with Angeli's salt. , 1995, The Biochemical journal.

[106]  I. Lizasoain,et al.  The formation of nitric oxide donors from peroxynitrite , 1995, British journal of pharmacology.

[107]  L. Rochelle,et al.  Interactions between hydroxocobalamin and nitric oxide (NO): evidence for a redox reaction between NO and reduced cobalamin and reversible NO binding to oxidized cobalamin. , 1995, The Journal of pharmacology and experimental therapeutics.

[108]  E. Block,et al.  Sulfhydryl-disulfide modulation and the role of disulfide oxidoreductases in regulation of the catalytic activity of nitric oxide synthase in pulmonary artery endothelial cells. , 1995, American journal of respiratory cell and molecular biology.

[109]  M. Rand,et al.  Discrimination by the NO‐trapping agent, carboxy‐PTIO, between NO and the nitrergic transmitter but not between NO and EDRF , 1995, British journal of pharmacology.

[110]  P. Vallance,et al.  Induction of NG-monomethyl-L-arginine uptake: a mechanism for differential inhibition of NO synthases? , 1995, The American journal of physiology.

[111]  D. Luo,et al.  Effects of methylene blue and LY83583 on neuronal nitric oxide synthase and NADPH-diaphorase. , 1995, European journal of pharmacology.

[112]  J. Garthwaite,et al.  Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. , 1995, Molecular pharmacology.

[113]  M. Rodríguez-Martínez,et al.  Nitric oxide, oxygen-derived free radicals and vascular endothelium. , 1995, Journal of autonomic pharmacology.

[114]  P. Klatt,et al.  Peroxynitrite-induced Accumulation of Cyclic GMP in Endothelial Cells and Stimulation of Purified Soluble Guanylyl Cyclase , 1995, The Journal of Biological Chemistry.

[115]  W. Martin,et al.  Differential sensitivity of basal and acetylcholine‐stimulated activity of nitric oxide to destruction by superoxide anion in rat aorta , 1995, British journal of pharmacology.

[116]  J. Brayden,et al.  Nitric oxide hyperpolarizes rabbit mesenteric arteries via ATP‐sensitive potassium channels. , 1995, The Journal of physiology.

[117]  P. Gallop,et al.  An NADPH oxidase superoxide-generating system in the rabbit aorta. , 1995, The American journal of physiology.

[118]  R. Sercombe,et al.  A new synthetic flavonoid protects endothelium-derived relaxing factor-induced relaxation in rabbit arteries in vitro: evidence for superoxide scavenging. , 1995, Biochemical pharmacology.

[119]  J. Stamler,et al.  NO+, NO, and NO- donation by S-nitrosothiols: implications for regulation of physiological functions by S-nitrosylation and acceleration of disulfide formation. , 1995, Archives of biochemistry and biophysics.

[120]  J. Hothersall,et al.  Copper chelation‐induced reduction of the biological activity of S‐nitrosothiols , 1995, British journal of pharmacology.

[121]  L. Ignarro,et al.  Formation of free nitric oxide from l-arginine by nitric oxide synthase: direct enhancement of generation by superoxide dismutase. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[122]  J. Wood,et al.  Models of the diffusional spread of nitric oxide: Implications for neural nitric oxide signalling and its pharmacological properties , 1994, Neuropharmacology.

[123]  E. Weitzberg,et al.  Intragastric nitric oxide production in humans: measurements in expelled air. , 1994, Gut.

[124]  S. Archer,et al.  Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[125]  M. A. Moro,et al.  Paradoxical fate and biological action of peroxynitrite on human platelets. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[126]  T. Cocks,et al.  Evidence for differential roles of nitric oxide (NO) and hyperpolarization in endothelium‐dependent relaxation of pig isolated coronary artery , 1994, British journal of pharmacology.

[127]  J. Charpie,et al.  A photoactivable source of relaxing factor in genetic hypertension. , 1994, Hypertension.

[128]  M. Feelisch,et al.  Bioassay discrimination between nitric oxide (NO.) and nitroxyl (NO-) using L-cysteine. , 1994, Biochemical and biophysical research communications.

[129]  N. Kooy,et al.  Agonist-induced peroxynitrite production from endothelial cells. , 1994, Archives of biochemistry and biophysics.

[130]  R. Cohen,et al.  Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle , 1994, Nature.

[131]  T. Malinski,et al.  Light-activated release of nitric oxide from vascular smooth muscle of normotensive and hypertensive rats. , 1994, Biochemical and biophysical research communications.

[132]  M. Rand,et al.  INHIBITION BY ETHACRYNIC ACID OF NO‐MEDIATED RELAXATIONS OF THE RAT ANOCOCCYGEUS MUSCLE , 1994, Clinical and experimental pharmacology & physiology.

[133]  B. Mutus,et al.  VISIBLE LIGHT PHOTOCHEMICAL RELEASE OF NITRIC OXIDE FROM S‐NITROSOGLUTATHIONE: POTENTIAL PHOTOCHEMOTHERAPEUTIC APPLICATIONS , 1994, Photochemistry and photobiology.

[134]  S. Moncada,et al.  Understanding the controversy over the identity of EDRF , 1994, Nature.

[135]  H. Nagasawa,et al.  Involvement of nitroxyl (HNO) in the cyanamide-induced vasorelaxation of rabbit aorta. , 1994, Biochemical pharmacology.

[136]  I. Leusen,et al.  Contribution of nitric oxide to the endothelium‐dependent hyperpolarization in rat aorta. , 1994, The Journal of physiology.

[137]  J. Beckman,et al.  Peroxynitrite, a product of superoxide and nitric oxide, produces coronary vasorelaxation in dogs. , 1994, The Journal of pharmacology and experimental therapeutics.

[138]  R. Gryglewski,et al.  Carboxyebselen a potent and selective inhibitor of endothelial nitric oxide synthase. , 1994, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[139]  V. Kharitonov,et al.  Kinetics of nitric oxide autoxidation in aqueous solution. , 1994, The Journal of biological chemistry.

[140]  F. Cosentino,et al.  Role of superoxide anions in the mediation of endothelium-dependent contractions. , 1994, Hypertension.

[141]  J. Stamler,et al.  Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[142]  J. McMurray,et al.  Effects of a Xanthine Oxidase/Hypoxanthine Free Radical and Reactive Oxygen Species Generating System on Endothelial Function in New Zealand White Rabbit Aortic Rings , 1993, Journal of cardiovascular pharmacology.

[143]  C. Pang,et al.  Vascular pharmacodynamics of NG-nitro-L-arginine methyl ester in vitro and in vivo. , 1993, The Journal of pharmacology and experimental therapeutics.

[144]  R. Gryglewski,et al.  Inhibition of endothelial nitric oxide synthase by ebselen. Prevention by thiols suggests the inactivation by ebselen of a critical thiol essential for the catalytic activity of nitric oxide synthase. , 1993, The Journal of pharmacology and experimental therapeutics.

[145]  R. Busse,et al.  Formation and release of dinitrosyl iron complexes by endothelial cells. , 1993, Biochemical and biophysical research communications.

[146]  C. Garland,et al.  Differential effects of acetylcholine, nitric oxide and levcromakalim on smooth muscle membrane potential and tone in the rabbit basilar artery , 1993, British journal of pharmacology.

[147]  R. Furchgott,et al.  Inhibition by sulfhydryl compounds of vascular relaxation induced by nitric oxide and endothelium-derived relaxing factor. , 1993, The Journal of pharmacology and experimental therapeutics.

[148]  M. Rand,et al.  Differential effects of hydroxocobalamin on relaxations induced by nitrosothiols in rat aorta and anococcygeus muscle. , 1993, European journal of pharmacology.

[149]  J. Catravas,et al.  Sulfhydryl-depleting agents, but not deferoxamine, modulate EDRF action in cultured pulmonary arterial cells. , 1993, The American journal of physiology.

[150]  S Moncada,et al.  Vascular smooth muscle contains a depletable store of a vasodilator which is light-activated and restored by donors of nitric oxide. , 1993, The Journal of pharmacology and experimental therapeutics.

[151]  L. Ignarro,et al.  Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from L-arginine. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[152]  B. E. Robertson,et al.  cGMP-dependent protein kinase activates Ca-activated K channels in cerebral artery smooth muscle cells. , 1993, The American journal of physiology.

[153]  D. Wink,et al.  Autoxidation kinetics of aqueous nitric oxide , 1993, FEBS letters.

[154]  P Tomboulian,et al.  Diffusion of nitric oxide in the aorta wall monitored in situ by porphyrinic microsensors. , 1993, Biochemical and biophysical research communications.

[155]  J. Stamler,et al.  NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. , 1993, The Journal of clinical investigation.

[156]  P. Park,et al.  NO- and NO2-carrying molecules potentiate photorelaxation in rat trachea and aorta. , 1993, Biochemical and biophysical research communications.

[157]  M. Kinoshita,et al.  Mechanisms of Endothelium‐Dependent Responses to Vasoactive Agents in Isolated Porcine Coronary Arteries , 1993, Journal of cardiovascular pharmacology.

[158]  H. Maeda,et al.  Antagonistic action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor/.NO through a radical reaction. , 1993, Biochemistry.

[159]  B. Mayer,et al.  Inhibition of nitric oxide synthesis by methylene blue. , 1993, Biochemical pharmacology.

[160]  M. Rand,et al.  Differential effects of hydroxocobalamin on NO‐mediated relaxations in rat aorta and anococcygeus muscle , 1993, British journal of pharmacology.

[161]  J. Stamler,et al.  Biochemistry of nitric oxide and its redox-activated forms. , 1992, Science.

[162]  J. Fukuto,et al.  The pharmacological activity of nitroxyl: a potent vasodilator with activity similar to nitric oxide and/or endothelium-derived relaxing factor. , 1992, The Journal of pharmacology and experimental therapeutics.

[163]  J. Catravas,et al.  Methylene blue inhibits nitrovasodilator- and endothelium-derived relaxing factor-induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion. , 1992, The Journal of pharmacology and experimental therapeutics.

[164]  P. Crack,et al.  Thimerosal blocks stimulated but not basal release of endothelium‐derived relaxing factor (EDRF) in dog isolated coronary artery , 1992, British journal of pharmacology.

[165]  J. Boucher,et al.  Cytochrome P450 catalyzes the oxidation of N omega-hydroxy-L-arginine by NADPH and O2 to nitric oxide and citrulline. , 1992, Biochemical and Biophysical Research Communications - BBRC.

[166]  C. N. Gillis,et al.  Enhanced photorelaxation in aorta, pulmonary artery and corpus cavernosum produced by BAY K 8644 or N-nitro-L-arginine. , 1992, Biochemical and biophysical research communications.

[167]  R. Cohen,et al.  EDTA influences reactivity of isolated aorta from hypercholesterolemic rabbits. , 1992, The American journal of physiology.

[168]  C. Garland,et al.  Evidence that nitric oxide does not mediate the hyperpolarization and relaxation to acetylcholine in the rat small mesenteric artery , 1992, British journal of pharmacology.

[169]  S. Marklund,et al.  Vascular bound recombinant extracellular superoxide dismutase type C protects against the detrimental effects of superoxide radicals on endothelium-dependent arterial relaxation. , 1992, Circulation research.

[170]  H. Sies,et al.  Reversible conversion of nitroxyl anion to nitric oxide by superoxide dismutase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[171]  A. Hobbs,et al.  Differentiation by hydroquinone of relaxations induced by exogenous and endogenous nitrates in non‐vascular smooth muscle: role of superoxide anions , 1991, British journal of pharmacology.

[172]  T. Amachi,et al.  Expression of a hybrid Cu/Zn-type superoxide dismutase which has high affinity for heparin-like proteoglycans on vascular endothelial cells. , 1991, The Journal of biological chemistry.

[173]  A. Vanin.  Endothelium‐derived relaxing factor is a nitrosyl iron complex with thiol ligands , 1991, FEBS letters.

[174]  M. Wolin,et al.  Inhibition of coronary artery superoxide dismutase attenuates endothelium-dependent and -independent nitrovasodilator relaxation. , 1991, Circulation research.

[175]  S. Snyder,et al.  Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase , 1991, Nature.

[176]  D. Harrison,et al.  Release of intact endothelium-derived relaxing factor depends on endothelial superoxide dismutase activity. , 1991, The American journal of physiology.

[177]  H. Fung,et al.  Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols. , 1990, The Journal of pharmacology and experimental therapeutics.

[178]  S. Moncada,et al.  Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo , 1990, British journal of pharmacology.

[179]  M. Wolin,et al.  Superoxide anion inhibits cGMP-associated bovine pulmonary arterial relaxation. , 1990, The American journal of physiology.

[180]  M. Wolin,et al.  Methylene blue inhibits vasodilation of skeletal muscle arterioles to acetylcholine and nitric oxide via the extracellular generation of superoxide anion. , 1990, The Journal of pharmacology and experimental therapeutics.

[181]  G. Dusting,et al.  Hyperpolarization and relaxation of arterial smooth muscle caused by nitric oxide derived from the endothelium , 1990, Nature.

[182]  J. Schrader,et al.  Control of coronary vascular tone by nitric oxide. , 1990, Circulation research.

[183]  D. Harrison,et al.  Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide , 1990, Nature.

[184]  J. Angus,et al.  Comparison of relaxation responses of vascular and non-vascular smooth muscle to endothelium-derived relaxing factor (EDRF), acidified sodium nitrite (NO) and sodium nitroprusside , 1990, Naunyn-Schmiedeberg's Archives of Pharmacology.

[185]  G. Dusting,et al.  INHIBITION OF ENDOTHELIAL NITRIC OXIDE BIOSYNTHESIS BY N‐NITRO‐l‐ARGININE , 1990, Clinical and experimental pharmacology & physiology.

[186]  B. Freeman,et al.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[187]  A. Gibson,et al.  l‐NG‐nitro arginine (l‐NOARG), a novel, l‐arginine‐reversible inhibitor of endothelium‐dependent vasodilatation in vitro , 1990, British journal of pharmacology.

[188]  M. Rand,et al.  EVIDENCE FOR A ROLE OF NITRIC OXIDE IN THE NEUROTRANSMITTER SYSTEM MEDIATING RELAXATION OF THE RAT ANOCOCCYGEUS MUSCLEC , 1989, Clinical and experimental pharmacology & physiology.

[189]  S Moncada,et al.  Biosynthesis of nitric oxide from L-arginine. A pathway for the regulation of cell function and communication. , 1989, Biochemical pharmacology.

[190]  R. Furchgott,et al.  Interactions of light and sodium nitrite in producing relaxation of rabbit aorta. , 1989, The Journal of pharmacology and experimental therapeutics.

[191]  J. Gillespie,et al.  Influence of haemoglobin and erythrocytes on the effects of EDRF, a smooth muscle inhibitory factor, and nitric oxide on vascular and non‐vascular smooth muscle , 1988, British journal of pharmacology.

[192]  G. Dusting,et al.  ENDOTHELIUM‐DERIVED RELAXING FACTOR RELEASED FROM CULTURED CELLS: DIFFERENTIATION FROM NITRIC OXIDE , 1988, Clinical and experimental pharmacology & physiology.

[193]  A. Gorren,et al.  The reaction of nitric oxide with copper proteins and the photodissociation of copper-NO complexes. , 1987, Biochimica et biophysica acta.

[194]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[195]  J. Hibbs,et al.  L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. , 1987, Journal of immunology.

[196]  S. Moncada,et al.  Mechanism of action of some inhibitors of endothelium-derived relaxing factor. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[197]  P. Vanhoutte,et al.  Oxygen-derived free radicals, endothelium, and responsiveness of vascular smooth muscle. , 1986, The American journal of physiology.

[198]  S. Moncada,et al.  Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor , 1986, Nature.

[199]  R. Paul,et al.  Eicosonoid metabolism and beta-adrenergic mechanisms in coronary arterial smooth muscle: potential compartmentation of cAMP. , 1986, The American journal of physiology.

[200]  D. L. Williams,et al.  S-Nitrosation and the reactions of S-nitroso compounds , 1985 .

[201]  R. Furchgott,et al.  Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. , 1985, The Journal of pharmacology and experimental therapeutics.

[202]  J. Karlsson,et al.  Effects of ultraviolet radiation on the tension and the cyclic GMP level of bovine mesenteric arteries. , 1984, Life sciences.

[203]  N. Yu,et al.  Resonance Raman studies of nitric oxide binding to ferric and ferrous hemoproteins: detection of Fe(III)--NO stretching, Fe(III)--N--O bending, and Fe(II)--N--O bending vibrations. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[204]  K. Folkers,et al.  Vitamin B12. XVI.1,2 Modifications of Cyano-cobalamin , 1951 .

[205]  N. Hogg.  The biochemistry and physiology of S-nitrosothiols. , 2002, Annual review of pharmacology and toxicology.

[206]  E. Weitzberg,et al.  Nitrite-derived nitric oxide: a possible mediator of 'acidic-metabolic' vasodilation. , 2001, Acta physiologica Scandinavica.

[207]  J. Charpie,et al.  Cyclic GMP-independent mechanisms of nitric oxide-induced vasodilation. , 1999, General pharmacology.

[208]  D. Wink,et al.  Effect of superoxide dismutase on the stability of S-nitrosothiols. , 1999, Archives of biochemistry and biophysics.

[209]  D. Pietraforte,et al.  Role of ascorbate and protein thiols in the release of nitric oxide from S-nitroso-albumin and S-nitroso-glutathione in human plasma. , 1997, Free radical biology & medicine.

[210]  E. Werner,et al.  Interference of carboxy-PTIO with nitric oxide- and peroxynitrite-mediated reactions. , 1997, Free radical biology & medicine.

[211]  J. Joseph,et al.  S-Nitrosoglutathione as a substrate for gamma-glutamyl transpeptidase. , 1997, The Biochemical journal.

[212]  S. Sasayama,et al.  Effect of ebselen on bovine and rat nitric oxide synthase activity is modified by thiols. , 1996, Japanese journal of pharmacology.

[213]  S. Watts,et al.  Photorelaxation is not attenuated by inhibition of the nitric oxide-cGMP pathway. , 1996, Journal of vascular research.

[214]  F. W. Flitney,et al.  Chemical mechanisms underlying the vasodilator and platelet anti-aggregating properties of S-nitroso-N-acetyl-DL-penicillamine and S-nitrosoglutathione. , 1995, Bioorganic & medicinal chemistry.

[215]  M. Blaustein,et al.  Inhibition of cytochrome P-450 reduces voltage-gated K+ currents in pulmonary arterial myocytes. , 1995, The American journal of physiology.

[216]  F. W. Flitney,et al.  NO, nitrosonium ions, nitroxide ions, nitrosothiols and iron-nitrosyls in biology: a chemist's perspective. , 1995, Trends in pharmacological sciences.

[217]  J. Fukuto,et al.  Chemistry of nitric oxide: biologically relevant aspects. , 1995, Advances in pharmacology.

[218]  F. W. Flitney,et al.  Repriming of Vascular Smooth Muscle Photorelaxation is Dependent upon Endothelium-derived Nitric Oxide , 1995 .

[219]  S. Snyder,et al.  Nitric oxide: a physiologic messenger molecule. , 1994, Annual review of biochemistry.

[220]  J. Bauer,et al.  Photochemical generation of nitric oxide from nitro-containing compounds: possible relation to vascular photorelaxation phenomena. , 1994, Life sciences.

[221]  S. Padmaja,et al.  The reaction of no with superoxide. , 1993, Free radical research communications.

[222]  R. Furchgott,et al.  Vasodilation induced by acetylcholine and by glyceryl trinitrate in rat aortic and mesenteric vasculature. , 1992, Journal of vascular research.

[223]  M. Feelisch.  The Biochemical Pathways of Nitric Oxide Formation from Nitrovasodilators: Appropriate Choice of Exogenous NO Donors and Aspects of Preparation and Handling of Aqueous NO Solutions , 1991 .

[224]  F. Murad,et al.  Effects of ethacrynic acid and cystamine on sodium nitroprusside-induced relaxation, cyclic GMP levels and guanylate cyclase activity in rat aorta. , 1988, General pharmacology.

[225]  L. Ignarro,et al.  Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation. , 1988, The Journal of pharmacology and experimental therapeutics.

[226]  R. Broene,et al.  Oxidation and reduction of hemoproteins by trioxodinitrate(II). The role of nitrosyl hydride and nitrite , 1988 .

[227]  R. Coppock,et al.  Inhibitory effects of various sulfur compounds on the activity of bovine erythrocyte enzymes. , 1987, Journal of toxicology and environmental health.